Ara
Toplam kayıt 1, listelenen: 1-1
Current clinician perspective on non-vitamin K antagonist oral anticoagulant use in challenging clinical cases
(2020)
Objective: The evolution of non-vitamin K antagonist anticoagulants (NOACs) has changed the horizon of stroke prevention in atrial fibrillation (SPAF). All 4 NOACs have been tested against dose-adjusted warfarin in ...